Ramsay Awardee Collaborates to Review Causes and Treatments for Cognitive Decline in People with ME/CFS
Dr. Katharine Seton is a research fellow at the Quadram Institute in Norwich, England, a
March 26, 2025
Dr. Katharine Seton is a research fellow at the Quadram Institute in Norwich, England, a
Tell Congress to Restore Our Research! Reverse the 57% Cut to the Congressionally Directed Medical
We are proud to announce the selection of the 2025-2026 Lived Experience Taskforce (LET), a
Registration in now open for Solve M.E.’s 2025 Advocacy Week June 23-27! With a new
Along with nearly 240 other organizations, Solve M.E. enthusiastically endorses the SSI Savings Penalty Elimination
This week, the House will vote on a continuing resolution to fund government programs through
In 2023, the Long COVID Alliance (co-founded by Solve M.E.) established a new Infection Associated
Dr. Deborah Duricka—affiliated assistant professor at the University of Alaska, researcher at Neuroversion, and Solve
People with Long Covid may participate in an important new clinical trial—the REVERSE-LC trial (Evaluating
Dr. Rob Wüst is a professor at the Vrije de Universiteit (Amsterdam, Netherlands) who specializes
Post-exertional malaise (PEM) is the most prominent and common symptom of ME/CFS, but researchers have
Solve CEO Emily Taylor and co-authors from esteemed organizations including the Bateman Horne Center; New
350 N Glendale Ave.
Suite B #368
Glendale, CA 91206
SolveCFS@SolveCFS.org
704-364-0016
EIN: 56-1683450
